- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x 01: 4-[4-[3-[2,4-bis(azanyl)-6-ethyl-pyrimidin-5-yl]oxypropoxy]phenyl]benzoic acid
01.2: 16 residues within 4Å:- Chain A: I.14, C.15, A.16, L.46, C.50, D.54, M.55, F.58, N.108, I.112, P.113, F.116, L.164, Y.170, T.185
- Ligands: NDP.1
10 PLIP interactions:10 interactions with chain A- Hydrophobic interactions: A:L.46, A:I.112, A:P.113, A:F.116
- Hydrogen bonds: A:I.14, A:C.15, A:Y.170, A:T.185
- Salt bridges: A:D.54
- pi-Stacking: A:F.58
01.6: 15 residues within 4Å:- Chain B: I.14, C.15, A.16, L.46, D.54, M.55, F.58, N.108, I.112, P.113, F.116, L.164, Y.170, T.185
- Ligands: NDP.5
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:L.46, B:F.116
- Hydrogen bonds: B:I.14, B:Y.170, B:T.185, B:T.185
- Salt bridges: B:D.54
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
UMP.3: 13 residues within 4Å:- Chain A: R.345, C.490, H.491, Q.509, R.510, S.511, D.513, G.517, N.521, H.551, Y.553
- Chain B: R.470, R.471
13 PLIP interactions:10 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:D.513
- Hydrogen bonds: A:Q.509, A:S.511, A:S.511, A:D.513, A:N.521, A:N.521, A:H.551
- Salt bridges: A:R.345, A:R.510, B:R.470, B:R.471
- Water bridges: B:R.470
UMP.8: 13 residues within 4Å:- Chain A: R.470, R.471
- Chain B: R.345, C.490, H.491, Q.509, R.510, S.511, D.513, G.517, N.521, H.551, Y.553
14 PLIP interactions:11 interactions with chain B, 3 interactions with chain A- Hydrogen bonds: B:Q.509, B:S.511, B:S.511, B:D.513, B:N.521, B:N.521, B:H.551, B:Y.553
- Water bridges: B:R.345, A:R.470
- Salt bridges: B:R.345, B:R.510, A:R.470, A:R.471
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.4: 5 residues within 4Å:- Chain A: Q.455, N.458, L.462, R.471
- Chain B: V.479
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:N.458, A:R.471
GOL.7: 6 residues within 4Å:- Chain A: V.479
- Chain B: V.453, Q.455, N.458, L.462, R.471
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.458, B:R.471
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Decharuangsilp, S. et al., Novel flexible biphenyl Pf DHFR inhibitors with improved antimalarial activity. Rsc Med Chem (2024)
- Release Date
- 2024-09-11
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.40 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x 01: 4-[4-[3-[2,4-bis(azanyl)-6-ethyl-pyrimidin-5-yl]oxypropoxy]phenyl]benzoic acid
- 2 x UMP: 2'-DEOXYURIDINE 5'-MONOPHOSPHATE(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Decharuangsilp, S. et al., Novel flexible biphenyl Pf DHFR inhibitors with improved antimalarial activity. Rsc Med Chem (2024)
- Release Date
- 2024-09-11
- Peptides
- Bifunctional dihydrofolate reductase-thymidylate synthase: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B